RBC upgrades Sartorius stocks as recent pullback ’provides entry opportunity’ 

Published 23/07/2025, 12:44

Investing.com -- RBC Capital Markets has upgraded its ratings on both Sartorius AG (ETR:SATG) and Sartorius Stedim (EPA:STDM) to Outperform from Sector Perform, highlighting the recent share price weakness as an opportunity to re-enter the names.

The brokerage believes that the roughly 14% pullback over the past two months has improved the risk-reward balance for both stocks.

“Underperformance over the last two months has swung the risk-reward to the upside,” analysts led by Charles Weston said in a Wednesday note, noting that the negative reaction to Sartorius’ recent in-line results contributed to the move lower.

While bioprocessing trends remain steady—with strong demand for consumables and persistently weak instrument sales—RBC sees room for upside if equipment demand recovers. Currently, equipment sales are acting as a drag of more than two percentage points on group sales. 

“We don’t know when this will recover, but when it does, we would expect it to turn to a >2ppt tailwind, driving earnings upside and multiple expansion,” the analysts said.

RBC trimmed its price target for Sartorius AG to €250 from €260, reflecting slightly adjusted estimates, including tariff-related revenue adjustments and modest earnings per share (EPS) downgrades for 2026 and 2027. 

The firm values Sartorius AG based on its 71.5% stake in Sartorius Stedim and an additional valuation for the Lab Products division, offset by higher debt levels.

Despite ongoing concerns around biotech funding, tariffs and pricing pressure in pharma, analysts believe sentiment could turn on signs of equipment recovery. 

Although Q2 results were broadly in line, the stock experienced “significant intraday volatility around messaging on order levels,” they said. 

RBC sees nearly 30% upside in Sartorius shares on a one-year view, supported by the potential for a rebound in equipment demand and stabilizing market sentiment.

In the wake of recent share price decline, the team believes that investors "have an opportunity to re-build their holdings at this level.”



Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.